Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 35Leukemia, Myeloid, Acute 35Myelodysplastic Syndromes 27Lymphoma, Non-Hodgkin 25Lymphoma 20Leukemia, Myelogenous, Chronic, BCR-ABL Positive 20Leukemia 20Hodgkin Disease 14Central Nervous System Neoplasms 13Breast Neoplasms 13Hematologic Neoplasms 12Leukemia, Lymphocytic, Chronic, B-Cell 11Neuroblastoma 9Burkitt Lymphoma 9Multiple Myeloma 8Lymphoma, Large B-Cell, Diffuse 8Myeloproliferative Disorders 7Leukemia, Myeloid, Accelerated Phase 7Leukemia, Biphenotypic, Acute 7Lymphoma, Follicular 6Graft vs Host Disease 6Dendritic Cell Sarcoma, Interdigitating 6Congenital Abnormalities 6Brain Neoplasms 6Blast Crisis 6Anemia, Refractory, with Excess of Blasts 6Testicular Neoplasms 5Lymphoma, Mantle-Cell 5Lymphoma, Large-Cell, Immunoblastic 5Lymphoma, B-Cell, Marginal Zone 5

Interventions

carotuximab 2Bevacizumab 2pegylated granulocyte colony-stimulating factor 1pegfilgrastim 1Thiotepa 1Specimen Handling 1Second-Look Surgery 1Reoperation 1Radiotherapy 1Radiation 1Peripheral Blood Stem Cell Transplantation 1Pemetrexed 1Mesna 1Magnetic Resonance Spectroscopy 1Ifosfamide 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Etoposide 1Drug Therapy 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Choriocarcinoma × Thiotepa × Clear all
NCT04684368 2026-05-05

A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT

Children's Oncology Group

Phase 2 Recruiting
160 enrolled

Choriocarcinoma, Teratoma, Carcinoma, Embryonal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡